Published in J Mol Biol on January 15, 1974
Ribosomal protein S1 and polypeptide chain initiation in bacteria. Proc Natl Acad Sci U S A (1975) 1.45
Restoration by ribosomal protein S1 of the defective translation in a temperature-sensitive mutant of Escherichia coli K-12: characterization and genetic studies. J Bacteriol (1976) 1.08
Specific binding of messenger RNA and methionyl-tRNAfMet by the same initiation factor for eukaryotic protein synthesis. Proc Natl Acad Sci U S A (1978) 1.05
Escherichia coli ribosomal protein S1 has two polynucleotide binding sites. Proc Natl Acad Sci U S A (1977) 1.04
Replacement of ribosomal protein S1 by interference factor ialpha in ribosomal binding of phage Ms2 RNA. Proc Natl Acad Sci U S A (1974) 0.98
Sequence of events in initiation of translation: a role for initiator transfer RNA in the recognition of messenger RNA. Proc Natl Acad Sci U S A (1974) 0.93
Discriminative effect of rifampin of RNA replication of various RNA bacteriophages. J Virol (1975) 0.89
The Bacillus subtilis nucleoid-associated protein HPB12 strongly compacts DNA. J Bacteriol (1994) 0.78
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Localization of the ASV src gene product to the plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell (1979) 4.30
The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science (1987) 4.01
Identification of the SV40 agnogene product: a DNA binding protein. Nature (1981) 3.80
p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A (1981) 3.72
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med (2000) 2.55
Unusual features in the nucleotide sequence of a cDNA clone derived from the common region of avian sarcoma virus messenger RNA. Proc Natl Acad Sci U S A (1980) 2.45
Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science (1985) 2.23
Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science (1985) 2.22
Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. Proc Natl Acad Sci U S A (1984) 2.17
Secretion of a transplantation-related antigen. Cell (1983) 2.12
A nonpolymorphic class I gene in the murine major histocompatibility complex. Cell (1984) 2.12
Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science (1989) 2.08
The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol (1986) 2.08
A transgenic mouse model for human neurofibromatosis. Science (1987) 2.05
The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet (1995) 2.03
Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon. Nature (1982) 2.01
Gene expression: chemical synthesis of E. coli ribosome binding sites and their use in directing the expression of mammalian proteins in bacteria. Nucleic Acids Res (1982) 2.01
Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature (1989) 1.98
The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol (1990) 1.91
Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem (1996) 1.85
Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet (1995) 1.80
Tissue-specific expression of an unusual H-2 (class I)-related gene. Proc Natl Acad Sci U S A (1982) 1.76
Identification of a transformation-specific protein induced by a Rous sarcoma virus. Cell (1978) 1.74
A common transformation-related protein in murine sarcomas and leukemias. Cold Spring Harb Symp Quant Biol (1980) 1.74
Discrete regions of simian virus 40 large T antigen are required for nonspecific and viral origin-specific DNA binding. J Virol (1982) 1.71
Human error in medicine: promise and pitfalls, part 2. Ann Emerg Med (2000) 1.61
Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu Rev Immunol (1988) 1.60
Simian virus 40-specific ribosome-binding proteins induced by a nondefective adenovirus 2-simian virus 40 hybrid. J Virol (1977) 1.59
Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus. Proc Natl Acad Sci U S A (1984) 1.58
Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem (2000) 1.57
New chimeric splice junction in adenovirus type 2-simian virus 40 hybrid viral mRNA. J Virol (1980) 1.53
A transcriptional enhancer and an interferon-responsive sequence in major histocompatibility complex class I genes. Mol Cell Biol (1986) 1.50
Characterization of an immune complex kinase in immunoprecipitates of avian sarcoma virus-transformed fibroblasts. J Virol (1979) 1.48
Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. Nature (1982) 1.48
Regulated expression of a murine class I gene in transgenic mice. Mol Cell Biol (1986) 1.44
Developmental activation of the H-2K gene is correlated with an increase in DNA methylation. Cell (1983) 1.44
Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sci U S A (1986) 1.43
Simian virus 40 tumor antigen: isolation of the origin-specific DNA-binding domain. J Virol (1983) 1.42
Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon. Cell (1985) 1.41
Expression of the complete human T-cell leukemia virus type I pX coding sequence as a functional protein in Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.41
Translational control: recognition of the methylated 5' end and an internal sequence in eukaryotic mRNA by the initiation factor that binds methionyl-tRNAfMet. Proc Natl Acad Sci U S A (1978) 1.39
Regulation of human interleukin-2 and interferon-gamma gene expression by suppressor T lymphocytes. Scand J Immunol (1991) 1.39
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med (1997) 1.38
Inhibition of cellular protein synthesis by double-stranded RNA: inactivation of an initiation factor. Proc Natl Acad Sci U S A (1973) 1.36
The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell (1986) 1.35
Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J Exp Med (1988) 1.34
Ribosomal subunit exchange in the cytoplasm of a eukaryote. Nature (1969) 1.33
Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest (1996) 1.33
Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology (1989) 1.32
Construction of a general vector for efficient expression of mammalian proteins in bacteria: use of a synthetic ribosome binding site. Proc Natl Acad Sci U S A (1981) 1.31
Molecular mechanism for the capture and excision of the transforming gene of avian sarcoma virus as suggested by analysis of recombinant clones. J Virol (1980) 1.31
Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J Clin Invest (1997) 1.31
A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR. Genes Dev (1999) 1.30
Dissociation of ribosomes on polypeptide chain termination and origin of single ribosomes. Nature (1970) 1.30
p53 transformation-related protein: detection of an associated phosphotransferase activity. Proc Natl Acad Sci U S A (1981) 1.30
Subcellular localization of the simian virus 40 agnoprotein. J Virol (1983) 1.29
Functional insertion of an Alu type 2 (B2 SINE) repetitive sequence in murine class I genes. Science (1984) 1.28
Translational control of hemoglobin synthesis by an initiation factor required for recycling of ribosomes and for their binding to messenger RNA. Proc Natl Acad Sci U S A (1972) 1.28
Ribosomal subunit exchange during protein synthesis. Proc Natl Acad Sci U S A (1968) 1.26
Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells. Proc Natl Acad Sci U S A (1986) 1.24
Comparison of class I (H-2) gene sequences. Derivation of unique probes for members of this multigene family. J Biol Chem (1983) 1.23
Altering the boundaries of Hox3.1 expression: evidence for antipodal gene regulation. Cell (1992) 1.21
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Alternative RNA splicing in expression of the H-2K gene. Nature (1984) 1.19
Specific binding of a chemically synthesized prokaryotic ribosome recognition site. Prospect for molecular cloning and expression of eukaryotic genes. J Biol Chem (1980) 1.18
Cell-free synthesis of mouse H-2 histocompatibility antigens. Proc Natl Acad Sci U S A (1979) 1.16
Transgenic mouse model for central nervous system demyelination. Mol Cell Biol (1991) 1.15
Translational control by messenger RNA competition for eukaryotic initiation factor 2. J Biol Chem (1982) 1.15
Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol (1989) 1.13
Structural analysis of the gene encoding human gastrin: the large intron contains an Alu sequence. Proc Natl Acad Sci U S A (1984) 1.13
trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol Cell Biol (1989) 1.12
Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection. J Exp Med (1987) 1.08
Specific binding of eukaryotic initiation factor 2 to satellite tobacco necrosis virus RNA at a 5'-terminal sequence comprising the ribosome binding site. Proc Natl Acad Sci U S A (1981) 1.06
Competition between alpha- and beta-globin messenger ribonucleic acids for eucaryotic initiation factor 2. Biochemistry (1979) 1.06
Specific binding of messenger RNA and methionyl-tRNAfMet by the same initiation factor for eukaryotic protein synthesis. Proc Natl Acad Sci U S A (1978) 1.05
Transgenic mouse model for human gastric carcinoma. Proc Natl Acad Sci U S A (1989) 1.04
Studies of ribosomal subunit exchange. Cold Spring Harb Symp Quant Biol (1969) 1.04
Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogene. Proc Natl Acad Sci U S A (1988) 1.02
The role of major histocompatibility complex class I antigens in tumorigenesis: future applications in cancer therapy. Biochim Biophys Acta (1989) 1.02
The molecular basis for the generation of the human soluble interleukin 2 receptor. Cytokine (1990) 1.01
Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit. Proc Natl Acad Sci U S A (1982) 1.01
Biosynthesis, immunological specificity, and intracellular distribution of the simian virus 40-specific protein induced by the nondefective hybrid Ad2+ND1. J Virol (1978) 1.00
Stress and exercise among the Japanese elderly. Soc Sci Med (1993) 1.00
Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. Am J Pathol (1993) 1.00
Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock. J Leukoc Biol (2001) 1.00
Genomic RNA of mengovirus V. Recognition of common features by ribosomes and eucaryotic initiation factor 2. J Virol (1982) 1.00
Tumor-specific transplantation antigen: use of the Ad2+ND1 hybrid virus to identify the protein responsible for simian virus 40 tumor rejection and its genetic origin. Proc Natl Acad Sci U S A (1978) 0.99
Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastoma. J Virol (1990) 0.97
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol (1991) 0.97
Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene. Mol Cell Biol (1988) 0.97
Human immunodeficiency virus-associated vasculopathy in transgenic mice. J Virol (1997) 0.96
Translational repression of a viral messenger RNA by a host protein. J Biol Chem (1975) 0.96
Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res (1991) 0.96
Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J Biol Chem (1994) 0.95
Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation. J Immunol (1989) 0.95